Sagacity Diagnostics: ResourcesInsights and perspectives on rare disease diagnosis, patient finding, and building trustworthy clinical decision support with PathfindEHR™.https://sagacitydiagnostics.com/Finding clarity amidst complexityhttps://sagacitydiagnostics.com/resources/finding-clarity-in-complexity/https://sagacitydiagnostics.com/resources/finding-clarity-in-complexity/The idea behind the Sagacity name, and why, after 25 years commercializing diagnostics, I believe the hard part isn't the science but connecting innovation to the patients who need it.Fri, 12 Jun 2026 00:00:00 GMTWhat commercializing diagnostics taught me about complexityhttps://sagacitydiagnostics.com/resources/what-complexity-taught-me/https://sagacitydiagnostics.com/resources/what-complexity-taught-me/Twenty-five years bringing diagnostics to market taught me that the science is rarely the bottleneck. Reflections on adoption, trust, and why the best technology amplifies the people on the front line.Wed, 10 Jun 2026 00:00:00 GMTFHIR and real-world data: the foundation for finding patientshttps://sagacitydiagnostics.com/resources/fhir-real-world-data/https://sagacitydiagnostics.com/resources/fhir-real-world-data/Why a standards-based, in-warehouse approach to FHIR and real-world data is the right foundation for rare disease patient finding: no migration, no PHI moved.Wed, 03 Jun 2026 00:00:00 GMTWhat to look for in a patient-finding platformhttps://sagacitydiagnostics.com/resources/what-to-look-for-in-a-patient-finding-platform/https://sagacitydiagnostics.com/resources/what-to-look-for-in-a-patient-finding-platform/Evaluating a patient-finding platform? The demo is the easy part. The questions that reveal whether it holds up: reproducibility, governance, explainability.Wed, 27 May 2026 00:00:00 GMTWhy rare disease definitions belong under governance, not in a prompthttps://sagacitydiagnostics.com/resources/governed-disease-pathways/https://sagacitydiagnostics.com/resources/governed-disease-pathways/If two runs of a patient-finding tool produce different cohorts, that's a liability, not a tool. How governed, KOL-validated definitions stay reproducible.Wed, 20 May 2026 00:00:00 GMTPatient finding is a partnership, not a transactionhttps://sagacitydiagnostics.com/resources/patient-finding-is-a-partnership/https://sagacitydiagnostics.com/resources/patient-finding-is-a-partnership/The most durable work in rare disease happens when health systems, clinicians, and life-science partners share a goal, and a clear data boundary. How we think about building those partnerships.Wed, 13 May 2026 00:00:00 GMTFinding the undiagnosed: surfacing rare disease patients in EHR datahttps://sagacitydiagnostics.com/resources/finding-undiagnosed-patients-in-ehr/https://sagacitydiagnostics.com/resources/finding-undiagnosed-patients-in-ehr/The evidence pointing to a rare disease diagnosis is often already in the chart. Here's how computational phenotyping over real-world EHR data finds the patients no one has connected yet.Wed, 06 May 2026 00:00:00 GMTThe case for finding patients earlierhttps://sagacitydiagnostics.com/resources/the-case-for-finding-patients-earlier/https://sagacitydiagnostics.com/resources/the-case-for-finding-patients-earlier/Earlier diagnosis isn't only kinder. For many rare diseases it changes outcomes and the economics of innovation. The strategic case for finding patients sooner.Wed, 29 Apr 2026 00:00:00 GMTThe rare disease diagnostic odyssey, by the numbershttps://sagacitydiagnostics.com/resources/diagnostic-odyssey/https://sagacitydiagnostics.com/resources/diagnostic-odyssey/Rare disease patients wait years and see many specialists before an answer. What the data says about the diagnostic odyssey, and where the delay comes from.Wed, 15 Apr 2026 00:00:00 GMT